These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 26764324

  • 1. Aged Garlic Extract Inhibits Human Platelet Aggregation by Altering Intracellular Signaling and Platelet Shape Change.
    Rahman K, Lowe GM, Smith S.
    J Nutr; 2016 Feb; 146(2):410S-415S. PubMed ID: 26764324
    [Abstract] [Full Text] [Related]

  • 2. Aged garlic extract inhibits platelet activation by increasing intracellular cAMP and reducing the interaction of GPIIb/IIIa receptor with fibrinogen.
    Allison GL, Lowe GM, Rahman K.
    Life Sci; 2012 Dec 17; 91(25-26):1275-80. PubMed ID: 23069586
    [Abstract] [Full Text] [Related]

  • 3. Activation of haem-oxidized soluble guanylyl cyclase with BAY 60-2770 in human platelets lead to overstimulation of the cyclic GMP signaling pathway.
    Mendes-Silverio CB, Leiria LO, Morganti RP, Anhê GF, Marcondes S, Mónica FZ, De Nucci G, Antunes E.
    PLoS One; 2012 Dec 17; 7(11):e47223. PubMed ID: 23144808
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The use of oxyhaemoglobin to explore the events underlying inhibition of platelet aggregation induced by NO or NO-donors.
    Salvemini D, Radziszewski W, Korbut R, Vane J.
    Br J Pharmacol; 1990 Dec 17; 101(4):991-5. PubMed ID: 1707709
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Oncocalyxone A inhibits human platelet aggregation by increasing cGMP and by binding to GP Ibalpha glycoprotein.
    Ferreira MA, do Nascimento NR, de Sousa CM, Pessoa OD, de Lemos TL, Ventura JS, Schattner M, Chudzinski-Tavassi AM.
    Br J Pharmacol; 2008 Jul 17; 154(6):1216-24. PubMed ID: 18516074
    [Abstract] [Full Text] [Related]

  • 9. Synergistic interaction of adenylate cyclase activators and nitric oxide donor SIN-1 on platelet cyclic AMP.
    Fisch A, Michael-Hepp J, Meyer J, Darius H.
    Eur J Pharmacol; 1995 May 26; 289(3):455-61. PubMed ID: 7556414
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
    Bilodeau ML, Hamm HE.
    J Pharmacol Exp Ther; 2007 Aug 26; 322(2):778-88. PubMed ID: 17525299
    [Abstract] [Full Text] [Related]

  • 12. The anti-aggregating effect of BAY 41-2272, a stimulator of soluble guanylyl cyclase, requires the presence of nitric oxide.
    Roger S, Badier-Commander C, Paysant J, Cordi A, Verbeuren TJ, Félétou M.
    Br J Pharmacol; 2010 Nov 26; 161(5):1044-58. PubMed ID: 20977455
    [Abstract] [Full Text] [Related]

  • 13. Role of soluble guanylyl cyclase-cyclic GMP signaling in tumor cell proliferation.
    Mujoo K, Sharin VG, Martin E, Choi BK, Sloan C, Nikonoff LE, Kots AY, Murad F.
    Nitric Oxide; 2010 Jan 01; 22(1):43-50. PubMed ID: 19948239
    [Abstract] [Full Text] [Related]

  • 14. Nitric oxide-sensitive guanylyl cyclase is the only nitric oxide receptor mediating platelet inhibition.
    Dangel O, Mergia E, Karlisch K, Groneberg D, Koesling D, Friebe A.
    J Thromb Haemost; 2010 Jun 01; 8(6):1343-52. PubMed ID: 20149081
    [Abstract] [Full Text] [Related]

  • 15. Adenosine increases human platelet levels of cGMP through nitric oxide: possible role in its antiaggregating effect.
    Anfossi G, Russo I, Massucco P, Mattiello L, Cavalot F, Balbo A, Trovati M.
    Thromb Res; 2002 Jan 01; 105(1):71-8. PubMed ID: 11864710
    [Abstract] [Full Text] [Related]

  • 16. YC-1 potentiates nitric oxide- and carbon monoxide-induced cyclic GMP effects in human platelets.
    Friebe A, Müllershausen F, Smolenski A, Walter U, Schultz G, Koesling D.
    Mol Pharmacol; 1998 Dec 01; 54(6):962-7. PubMed ID: 9855623
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A potential role for extracellular nitric oxide generation in cGMP-independent inhibition of human platelet aggregation: biochemical and pharmacological considerations.
    Crane MS, Rossi AG, Megson IL.
    Br J Pharmacol; 2005 Mar 01; 144(6):849-59. PubMed ID: 15685209
    [Abstract] [Full Text] [Related]

  • 19. Roles for both cyclic GMP and cyclic AMP in the inhibition of collagen-induced platelet aggregation by nitroprusside.
    Jang EK, Azzam JE, Dickinson NT, Davidson MM, Haslam RJ.
    Br J Haematol; 2002 Jun 01; 117(3):664-75. PubMed ID: 12028040
    [Abstract] [Full Text] [Related]

  • 20. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3.
    Feijge MA, Ansink K, Vanschoonbeek K, Heemskerk JW.
    Biochem Pharmacol; 2004 Apr 15; 67(8):1559-67. PubMed ID: 15041473
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.